The traditional method presents a two-stage trial design: a small group of patients is enrolled in the first stage; in the second stage, a second group of patients joins the trial based on the outcome of the first. If at the end of the first stage, only a few responses are observed, the trial is stopped for futility; otherwise, it proceeds to the second stage.
Compared to the traditional methods, Simon’s two-stage design modifications allow sample size adjustment during the course of the trial and enables companies to dynamically monitor the data and possible study outcome.
This method can be used to analyze early efficacy signals in a single-arm study. Applications include early oncology clinical trials or trials with inherently small populations, such as those for rare diseases.
